WALTHAM, Mass., March 28, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Mary Lynne Hedley, Ph.D., President and Chief Scientific Officer, will present at the 20 th Annual Future Leaders in the Biotech Industry Conference at the Millennium Broadway Hotel and Conference Center in New York City on Friday, April 5, 2013 at 1:30 p.m. EDT.
Interested parties may access a live audio webcast of the presentation via the investors section of the TESARO website, www.tesarobio.com . A replay of the webcast will be archived on the TESARO website for 14 days.
About TESAROTESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. The TESARO, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13456
CONTACT: For further information contact: Jennifer Davis Senior Director, Corporate Development and Investor Relations +1.781.325.1116 firstname.lastname@example.org
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV